Lv0
0 积分 2023-11-30 加入
Normocalcemic Primary Hyperparathyroidism: From Pathophysiology to Clinical Management
12小时前
待确认
Defining cure in patients with normocalcemic primary hyperparathyroidism: Should calcium or PTH be used?
12小时前
待确认
Normocalcemic Primary Hyperparathyroidism: An Evolving Understanding
13小时前
求助中
Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer
10个月前
已完结
Inflammatory breast cancer biomarkers and biology
10个月前
已完结
Inflammatory breast cancer: An overview about the histo-pathological aspect and diagnosis
10个月前
已完结
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
10个月前
已完结
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
10个月前
已完结
皖公网安备34019202002308
